(MENAFNEditorial) iCrowdNewswire - Jan 17, 2018
WiseGuyReports.com adds 'United States Transdermal Drug Delivery System Market by Manufacturers, States, Type and Application, Forecast to 2022 reports to its Database.
is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Scope of the Report:
This report focuses on the Transdermal Drug Delivery System in United States market, to split the market based on manufacturers, states, type and application.
Market Segment by Manufacturers, this report covers
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Market Segment by Type, covers
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Market Segment by Applications, can be divided into
OTC
Rx
Request For Sample Report @
Table Of Contents
1 Market Overview
1.1 Transdermal Drug Delivery System Introduction
1.2 Market Analysis by Type
1.2.1 Fentanyl
1.2.2 Nitroglycerin
1.2.3 Estradiol
1.2.4 Nicotine
1.2.5 Other
1.3 Market Analysis by Applications
1.3.1 OTC
1.3.2 Rx
1.4 Market Analysis by States
1.4.1 California Status and Prospect (2012-2022)
1.4.2 Texas Status and Prospect (2012-2022)
1.4.3 New York Status and Prospect (2012-2022)
1.4.4 Florida Status and Prospect (2012-2022)
1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hisamitsu
2.1.1 Profile
2.1.2 Transdermal Drug Delivery System Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Hisamitsu News
2.2 Mylan
2.2.1 Profile
2.2.2 Transdermal Drug Delivery System Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Mylan Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Mylan News
2.3 GSK
2.3.1 Profile
2.3.2 Transdermal Drug Delivery System Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 GSK Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 GSK News
2.4 Novartis
2.4.1 Profile
2.4.2 Transdermal Drug Delivery System Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Novartis Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Novartis News
2.5 Teve (Actavis)
2.5.1 Profile
2.5.2 Transdermal Drug Delivery System Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Teve (Actavis) News
Continued…….
Complete Report Details @
Contact Information:
CONTACT US:
NORAH TRENT
Partner Relations & Marketing Manager
rts.com
www.wiseguyreports.com
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
MENAFN1701201800703403ID1096364718
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.